首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
【2h】

Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.

机译:多发性硬化症中髓磷脂碱性蛋白特异性T淋巴细胞库。由于募集了多个T细胞克隆嵌套表位的响应和优势的复杂性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The human T cell response to the myelin basic protein (MBP) has been studied with respect to T cell receptor (TCR) usage, HLA class II restriction elements, and epitope specificity using a total of 215 long-term MBP-specific T cell lines (TCL) isolated from the peripheral blood of 13 patients with multiple sclerosis (MS) and 10 healthy donors. In most donors, the anti-MBP response was exceedingly heterogeneous. Using a panel of overlapping synthetic peptides spanning the entire length of human MBP, at least 26 epitopes recognized by human TCL could be distinguished. The MBP domain most commonly recognized was sequence 80-105 (31% of MS TCL, and 24% of control TCL). Sequence 29-48 was recognized more frequently by control-derived TCL (24%) than by TCL from MS patients (5%). The MBP epitopes were recognized in the context of DRB1 *0101, DRB5*0101, DRB1*1501, DRB1*0301, DRB1*0401, DRB1*1402, and DRB3*0102, as demonstrated using a panel of DR gene-transfected L cells. The TCR gene usage was also heterogeneous. V beta 5.2, a peptide of which is currently being used in a clinical trial for treatment of MS patients, was expressed by only one of our TCL. However, within this complex pattern of MBP-specific T cell responses, a minority of MS patients were found to exhibit a more restricted response with respect to their TCL epitope specificity. In these patients 75-87% of the TCL responded to a single, patient-specific cluster of immunodominant T cell epitopes located within a small (20-amino acid) domain of MBP. These nested clusters of immunodominant epitopes were noted within the amino acids 80-105, 108-131, and 131-153. The T cell response to the immunodominant epitopes was not monoclonal, but heterogeneous, with respect to fine specificity, TCR usage, and even HLA restriction. In one patient (H.K.), this restricted epitope profile remained stable for > 2 yr. The TCR beta chain sequences of TCL specific for the immunodominant region of HK are consistent with an oligoclonal response against the epitopes of this region (80-105). Further, two pairs of identical sequences were established from TCL generated from this patient at different times (June 1990 and June 1991), suggesting that some TCL specific for the immunodominant region persisted in the peripheral repertoire. The possible role of persistent immunodominant epitope clusters in the pathogenesis of MS remains to be established.
机译:已经研究了人类T细胞对髓鞘碱性蛋白(MBP)的反应,涉及T细胞受体(TCR)的使用,HLA II类限制元件和表位特异性,总共使用了215种长期MBP特异性T细胞系(TCL)从13位多发性硬化症(MS)患者和10位健康供体的外周血中分离出来。在大多数供体中,抗MBP反应极为不同。使用跨越人MBP整个长度的一组重叠的合成肽,可以区分人TCL识别的至少26个表位。最常见的MBP结构域是序列80-105(MS TCL为31%,对照TCL为24%)。对照来源的TCL(24%)比MS患者的TCL(5%)更频繁地识别序列29-48。 MBP表位在DRB1 * 0101,DRB5 * 0101,DRB1 * 1501,DRB1 * 0301,DRB1 * 0401,DRB1 * 1402和DRB3 * 0102的背景下被识别,如一组DR基因转染的L细胞所示。 TCR基因的用法也是异类的。 V beta 5.2仅由我们的一个TCL表示,该肽目前正在临床试验中用于治疗MS患者。但是,在这种复杂的MBP特异性T细胞反应模式中,发现少数MS患者在其TCL表位特异性方面表现出更为受限的反应。在这些患者中,TCL的75-87%对位于MBP小(20个氨基酸)结构域中的一个特定于患者的免疫优势T细胞表位簇产生了反应。这些嵌套的免疫优势表位簇在氨基酸80-105、108-131和131-153中被注意到。就精细特异性,TCR使用甚至HLA限制而言,T细胞对免疫优势表位的反应不是单克隆的,而是异质的。在一名患者中(香港),这种受限制的表位特征在超过2年的时间内保持稳定。对HK的免疫优势区域具有特异性的TCL的TCRβ链序列与针对该区域表位的寡克隆反应一致(80-105)。此外,从该患者在不同时间(1990年6月和1991年6月)产生的TCL建立了两对相同的序列,这表明一些特定于免疫优势区域的TCL仍存在于外周血库中。持久性免疫优势表位簇在MS发病机理中的可能作用尚待确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号